CASTLE BIOSCIENCES INC — Director's Dealing 2020

Sep 9, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CASTLE BIOSCIENCES INC (CSTL)
CIK: 0001447362
Period of Report: 2020-09-04

Reporting Person: Spiess Bernhard E. (Chief Business Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-09-04	Common Stock	S	20000	$47	Disposed	86747	Direct
2020-09-04	Common Stock	S	5112	$49	Disposed	81635	Direct
2020-09-08	Common Stock	S	14888	$49	Disposed	66747	Direct

Footnotes

F1: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on August 18, 2020.

F2: Includes 1,121 shares acquired under the Issuer's employee stock purchase plan on August 31, 2020.